Discover 1,416 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,416
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Sarasota FL, Durham NC, San Antonio TX, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase 1, Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
for
Prostatic Neoplasms
Location: Sarasota FL, Cleveland OH, New York NY
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07319871
Phase 1, Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Sarasota FL, Fairfax VA, Washington D.C. DC, Austin TX,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase 1, Recruiting
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
for
Advanced or Metastatic Adrenocortical Carcinoma,
Location: Sarasota FL, New York NY, Providence RI
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT07189403
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: Sarasota FL, New York NY, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07746713
Phase 1, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Sarasota FL, N. Venice FL, Venice FL, Ruskin FL,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase 3, Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
for
Advanced Solid Tumor
Location: Sarasota FL, Tampa FL, Houston TX, Pittsburgh PA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07070232
Phase 1, Phase 2, Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma